CDK2 and FOXO1: A Fork in the Road for Cell Fate Decisions

Haojie Huang and Donald J. Tindall

volume 6 | issue 8

15 April 2007
Pages: 902 - 906

We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:

Download PDF

If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.

It has been well established that cyclin-dependent kinases (CDKs) including CDK2 and CDK1 play an essential role in mediating cell-cycle arrest, DNA repair and apoptosis in cells with damaged genomes. Following DNA damage, the function of CDKs is inhibited, and therefore cells are arrested at the G1, S or G2/M phase of the cell-division cycle. It is believed that DNA damage-induced cell cycle arrest is important, because it allows cells to either repair the damage and survive or commit to apoptotic cell death. However, the molecular bases for the two cell fate options are not fully understood. Recently, we provided evidence that CDK2 interacts with and phosphorylates the forkhead transcription factor FOXO1. Importantly, activated CDK2 inhibits the pro-apoptotic function of FOXO1. However, in the presence of high levels of double-strand breaks (DSBs) the CDK2-mediated inhibition of FOXO1 is abrogated due to the ablation of CDK2 activity, and therefore the anti-apoptotic function of FOXO1 is restored. Thus, CDK2 silencing-dependent activation of FOXO1 represents a new mechanism that links DNA strand breakage to cell death.

Authors

Haojie Huang

University of Minnesota; Minneapolis, MN USA

Donald J. Tindall

Mayo Clinic College of Medicine; Rochester MN USA

We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link: